← Leaderboards
Zelig Eshhar
Tel-Aviv Sourasky Medical Center
$457,376
Attributed
$1,829,502
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $483.4K · FY2013–16$500K$375K$250K$125K$0
'13
'14
'15
'16
Funding mix
By agency
NIH$1,829,502 · 1
By mechanism
R01$1,829,502 · 1
Top collaborators
- Amer M Najjar4 shared
- David Steiner4 shared
- Pin Wang4 shared
Most similar at Tel-Aviv Sourasky Medical Center
Same institution · by research overlap
- Amer M Najjar$1,321,789
- David Steiner$457,376
Others in their field
Top investigators on “Gene Delivery”
- Elaine D. Eaker · Eaker Epidemiology Enterprises, Llc$63,680,802
- David Heimbrook · Leidos Biomedical Research, Inc.$54,204,250
- Tracey Devoir · Booz Allen Hamilton, Inc.$49,200,509
- Robert H Vonderheide · University Of Pennsylvania$45,163,553
- James Ter Maat · Social And Scientific Systems, Inc.$39,837,019
- Jeffrey S Chamberlain · University Of Michigan At Ann Arbor$35,106,464
Research focus
Gene DeliveryAblationFunding MechanismsBaseBiodistributionBlood SpecimenAntigen TargetingAdverse EffectsBypassCancer ImmunotherapyCd3 AntigensCell LineCell PreparationCellsCellular TransductionB Lymphoid MalignancyClinical TrialsBreast Cancer ModelDisease RemissionDrug Delivery SystemsEconomicsEventFlow CytometryGene Delivery System
Grant awards (4)
In situ Redirection of T cell Specificity and Imaging of Targeted CAR Expression.$483,404
R01 · FY2016 · EB · contact PI
In situ Redirection of T cell Specificity and Imaging of Targeted CAR Expression.$461,820
R01 · FY2015 · EB · contact PI
In situ Redirection of T cell Specificity and Imaging of Targeted CAR Expression.$426,075
R01 · FY2014 · EB · contact PI
In situ Redirection of T cell Specificity and Imaging of Targeted CAR Expression.$458,203
R01 · FY2013 · EB · contact PI